Theissen P, Schmidt M, Ivanova T, Dietlein M, Schicha H
Department of Nuclear Medicine, University of Cologne, Germany.
Nuklearmedizin. 2009;48(4):144-52. doi: 10.3413/nukmed-0240. Epub 2009 Jun 2.
Several authors have investigated the value of technetium-MIBI scanning to predict the dignity of hypofunctioning, cold thyroid nodules (HTN) in regions with differing levels of iodine supply. They concluded that an MIBI scan can exclude thyroid malignancy, although comparisons between the studies are of limited value owing to differences in methodology and wide variations in patient selection criteria. The present study investigates whether the above claim is also valid in Germany, a country with a long-standing and persistent, mild iodine deficiency and a high incidence of nodules in large goiters with a low prevalence of malignancy.
PATIENTS, METHODS: The study compares the results of 99mTc-MIBI scintigraphy (incl. SPECT and planar images) in HTN (MIBI) with those of fine-needle aspiration biopsy (FNAB) and histology. Of 154 consecutive patients (121 women, 33 men; mean age 56 +/- 12 years), 73 underwent thyroid surgery from which the results of FNAB and MIBI were assessed. Selection criteria were risk estimation or conditions limiting the feasibility of FNAB. The mean thyroid volume was 42 +/- 25 ml, with 2.1 +/- 1.4 nodules per patient.
Histology revealed thyroid malignancies in 8 out of 73 patients (11.0%). The negative predictive value for MIBI was 97%, which is comparable to FNAB (94%). However, in 19.5% of patients FNAB was indeterminate. Lower specificity (54%) and low positive predictive value (19%) showed that MIBI accumulation cannot differentiate between malignant and benign thyroid nodules. However, comparison with cytological and/or histological findings indicated that it could distinguish between lesions with differing rates of mitochondrial metabolism.
Even in areas of former or mild iodine deficiency MIBI forms a basis for choosing between wait-and-see and surgical strategies if FNAB is unfeasible or not representative. However, even for pathological MIBI results, the prevalence of malignancy is not very high.
几位作者研究了锝-甲氧基异丁基异腈(MIBI)扫描对预测不同碘供应水平地区功能减退的冷甲状腺结节(HTN)性质的价值。他们得出结论,MIBI扫描可以排除甲状腺恶性肿瘤,不过由于方法学差异以及患者选择标准的广泛变化,这些研究之间的比较价值有限。本研究调查了上述结论在德国是否也成立,德国长期存在轻度碘缺乏,大甲状腺肿中结节发生率高但恶性肿瘤患病率低。
本研究比较了HTN患者(MIBI组)的99mTc-MIBI闪烁扫描(包括单光子发射计算机断层扫描和平面图像)结果与细针穿刺活检(FNAB)及组织学结果。154例连续患者(121例女性,33例男性;平均年龄56±12岁)中,73例接受了甲状腺手术,对其FNAB和MIBI结果进行了评估。选择标准为风险评估或限制FNAB可行性的情况。平均甲状腺体积为42±25毫升,每位患者有2.1±1.4个结节。
73例患者中有8例(11.0%)经组织学检查发现甲状腺恶性肿瘤。MIBI的阴性预测值为97%,与FNAB(94%)相当。然而,19.5%的患者FNAB结果不确定。较低的特异性(54%)和低阳性预测值(19%)表明,MIBI摄取无法区分甲状腺恶性和良性结节。不过,与细胞学和/或组织学结果比较显示,它可以区分线粒体代谢率不同的病变。
即使在既往或轻度碘缺乏地区,如果FNAB不可行或不具有代表性,MIBI可为观察等待和手术策略的选择提供依据。然而,即使MIBI结果为病理性,恶性肿瘤的患病率也不是很高。